Progesterone and Vitamin D combination therapy modulates inflammatory response after traumatic brain injury

Brain Injury

Volumn 29, Issue 10, 2015, Pages 1165-1174

  Tang, Huiling ^a   Hua, Fang ^a   Wang, Jun ^a   Yousuf, Seema ^a   Atif, Fahim ^a   Sayeed, Iqbal ^a   Stein, Donald G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; frontal cortex; neuroprotection; neurosteroids; toll like receptors

Indexed keywords

PROGESTERONE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TOLL LIKE RECEPTOR 4; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BODY WEIGHT; BRAIN CONTUSION; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FRONTAL CORTEX; IMMUNOHISTOCHEMISTRY; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SURGICAL TECHNIQUE; TRAUMATIC BRAIN INJURY;

EID: 84939811586     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2015.1035330     Document Type: Article

References (55)

1. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: A double-edged sword. Current Opinion in Critical Care 2002; 8: 101-105
2. Loane DJ, Byrnes KR. Role of microglia in neurotrauma. Neurotherapeutics 2010; 7: 366-377
3. Amor S, Peferoen LA, Vogel DY, Breur M, van der Valk P, Baker D, van Noort JM. Inflammation in neurodegenerative diseases-an update. Immunology 2013; 142: 151-66.
4. Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: Translational challenges and emerging therapeutic strategies. Trends in Pharmacological Sciences 2010; 31: 596-604
5. McIntosh TK. Neuropathological sequelae of traumatic brain injury: Relationship to neurochemical and biomechanical mechanisms. Laboratory Investigation 1996; 74: 315-342
6. Hua F, Wang J, Ishrat T, Wei W, Atif F, Sayeed I, Stein DG. Genomic profile of toll-like receptor pathways in traumatically brain-injured mice: Effect of exogenous progesterone. Journal of Neuroinflammation 2011; 8: 42
7. Hua F, Ma J, Ha T, Xia Y, Kelley J, Williams DL, Kao RL, Browder IW, Schweitzer JB, Kalbfleisch JH, et al. Activation of toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. Journal of Neuroimmunology 2007; 190: 101-111
8. Michaud JP, Halle M, Lampron A, Theriault P, Prefontaine P, Filali M, Tribout-Jover P, Lanteigne AM, Jodoin R, Cluff C, et al. Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid a improves alzheimers disease-related pathology. Proceedings of the National Academy of Sciences USA 2013; 110: 1941-1946
9. Hanafy KA. The role of microglia and the tlr4 pathway in neuronal apoptosis and vasospasm after subarachnoid hemorrhage. Journal of Neuroinflammation 2013; 10: 83
10. Kenny EF, ONeill LA. Signalling adaptors used by toll-like receptors: An update. Cytokine 2008; 43: 342-349
11. Yamamoto Y, Gaynor RB. Ikappab kinases: Key regulators of the nf-kappab pathway. Trends in Biochemical Sciences 2004; 29: 72-79
12. Karin M, Yamamoto Y, Wang QM. The ikk nf-kappa b system: A treasure trove for drug development. Nature Reviews Drug Discovery 2004; 3: 17-26
13. Cederberg D, Siesjo P. What has inflammation to do with traumatic brain injury? Childs Nervous System 2010; 26: 221-226
14. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of cox-2 and inos through suppression of nf-kappa b activation. Mutat Res 2001; 480-481: 243-268
15. Strauss KI, Barbe MF, Marshall RM, Raghupathi R, Mehta S, Narayan RK. Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat. Journal of Neurotrauma 2000; 17: 695-711
16. Pahl HL. Activators and target genes of rel/nf-kappab transcription factors. Oncogene 1999; 18: 6853-6866
17. Harting MT, Jimenez F, Adams SD, Mercer DW, Cox CS Jr. Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy. Surgery 2008; 144: 803-813
18. Kong Y, Le Y. Toll-like receptors in inflammation of the central nervous system. International Immunopharmacology 2011; 11: 1407-1414
19. Hyakkoku K, Hamanaka J, Tsuruma K, Shimazawa M, Tanaka H, Uematsu S, Akira S, Inagaki N, Nagai H, Hara H. Toll-like receptor 4 (tlr4), but not tlr3 or tlr9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 2010; 171: 258-267
20. Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007; 115: 1599-1608
21. Shakeri M, Boustani MR, Pak N, Panahi F, Salehpour F, Lotfinia I, Meshkini A, Daghighi S, Vahedi P, Khani M, et al. Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma. Clinical Neurology & Neurosurgery 2013; 115: 2019-2022
22. Shahrokhi N, Haddad MK, Joukar S, Shabani M, Keshavarzi Z, Shahozehi B. Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury. Pakistan Journal of Pharmiceutical Science 2012; 25: 219-225
23. Barha CK, Ishrat T, Epp JR, Galea LA, Stein DG. Progesterone treatment normalizes the levels of cell proliferation and cell death in the dentate gyrus of the hippocampus after traumatic brain injury. Experimental Neurology 2011; 231: 72-81
24. De Nicola AF, Coronel F, Garay L, Gargiulo-Monachelli G, Deniselle EY, Gonzalez SL, Labombarda F, Meyer M, Guennoun R, et al. Therapeutic effects of progesterone in animal models of neurological disorders. CNS & Neurological Disorders-Drug Targets 2013; 12: 1205-1218
25. Su L, Sun Y, Ma F, Lu P, Huang H, Zhou J. Progesterone inhibits toll-like receptor 4-mediated innate immune response in macrophages by suppressing nf-kappab activation and enhancing socs1 expression. Immunology Letters 2009; 125: 151-155
26. Wang Z, Zuo G, Shi XY, Zhang J, Fang Q, Chen G. Progesterone administration modulates cortical tlr4/nf-kappab signaling pathway after subarachnoid hemorrhage in male rats. Mediators of Inflammation 2011; 2011: 848309
27. Ishrat T, Sayeed I, Atif F, Hua F, Stein DG. Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase b signaling pathway. Neuroscience 2012; 210: 442-450
28. Espinoza TR, Wright DW. The role of progesterone in traumatic brain injury. Journal of Head Trauma Rehabilitation 2011; 26: 497-499
29. Wong R, Renton C, Gibson CL, Murphy SJ, Kendall DA, Bath PM., Progesterone Pre-Clinical Stroke Pooling Project C. Progesterone treatment for experimental stroke: An individual animal meta-analysis. Journal of Cerebral Blood Flow & Metabolism 2013; 33: 1362-1372
30. Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein FC, Caveney AF, Howlett-Smith H, Bengelink EM, et al. Very early administration of progesterone for acute traumatic brain injury. New England Journal of Medicine 2014; 371: 2457-2466
31. Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, Nelson NR, Stocchetti N, the STI. A clinical trial of progesterone for severe traumatic brain injury. New England Journal of Medicine 2014; 371: 2467-76
32. Margulies S, Hicks R. Combination therapies for traumatic brain injury: Prospective considerations. Journal of Neurotrauma 2009; 26: 925-939
33. Hua F, Tang H, Wang J, Prunty MC, Hua X, Sayeed I, Stein DG. Tak-242, an antagonist for toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice. Journal of Cerebral Blood Flow & Metabolism 2015; 35: 536-42
34. Chen Y, Liu W, Sun T, Huang Y, Wang Y, Deb DK, Yoon D, Kong J, Thadhani R, Li YC. 1,25-dihydroxyvitamin d promotes negative feedback regulation of tlr signaling via targeting microrna-155-socs1 in macrophages. Journal of Immunology 2013; 190: 3687-3695
35. Thota C, Farmer T, Garfield RE, Menon R, Al-Hendy A. Vitamin d elicits anti-inflammatory response, inhibits contractile-associated proteins, and modulates toll-like receptors in human myometrial cells. Reproductive Sciences 2013; 20: 463-475
36. Atif F, Yousuf S, Sayeed I, Ishrat T, Hua F, Stein DG. Combination treatment with progesterone and vitamin d hormone is more effective than monotherapy in ischemic stroke: The role of bdnf/trkb/erk1/2 signaling in neuroprotection. Neuropharmacology 2013; 67: 78-87
37. Hua F, Reiss JI, Tang H, Wang J, Fowler X, Sayeed I, Stein DG. Progesterone and low-dose vitamin d hormone treatment enhances sparing of memory following traumatic brain injury. Hormones & Behavior 2012; 61: 642-651
38. Tang H, Hua F, Wang J, Sayeed I, Wang X, Chen Z, Yousuf S, Atif F, Stein DG. Progesterone and vitamin d: Improvement after traumatic brain injury in middle-aged rats. Hormones & Behavior 2013; 64: 527-538
39. Cutler SM, Cekic M, Miller DM, Wali B, VanLandingham JW, Stein DG. Progesterone improves acute recovery after traumatic brain injury in the aged rat. Journal of Neurotrauma 2007; 24: 1475-1486
40. Chen G, Shi J, Jin W, Wang L, Xie W, Sun J, Hang C. Progesterone administration modulates tlrs/nf-kappab signaling pathway in rat brain after cortical contusion. Annals of Clinical & Laboratory Science 2008; 38: 65-74
41. Grossman KJ, Goss CW, Stein DG. Effects of progesterone on the inflammatory response to brain injury in the rat. Brain Reserch 2004; 1008: 29-39
42. Pettus EH, Wright DW, Stein DG, Hoffman SW. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Research 2005; 1049: 112-119
43. Si D, Li J, Liu J, Wang X, Wei Z, Tian Q, Wang H, Liu G. Progesterone protects blood-brain barrier function and improves neurological outcome following traumatic brain injury in rats. Experimental & Therapeutic Medicine 2014; 8: 1010-1014
44. Gilmer LK, Roberts KN, Scheff SW. Efficacy of progesterone following a moderate unilateral cortical contusion injury. Journal of Neurotrauma 2008; 25: 593-602
45. Takeda K, Akira S. Tlr signaling pathways. Seminars in Immunology 2004; 16: 3-9
46. Ellis EF, Police RJ, Rice LY, Grabeel M, Holt S. Increased plasma pge2, 6-keto-pgf1 alpha, and 12-hete levels following experimental concussive brain injury. Journal of Neurotrauma 1989; 6: 31-37
47. Foley LM, Hitchens TK, Melick JA, Bayir H, Ho C, Kochanek PM. Effect of inducible nitric oxide synthase on cerebral blood flow after experimental traumatic brain injury in mice. Journal of Neurotrauma 2008; 25: 299-310
48. Sinz EH, Kochanek PM, Dixon CE, Clark RS, Carcillo JA, Schiding JK, Chen M, Wisniewski SR, Carlos TM, Williams D, et al. Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. Journal of Clinical Investigation 1999; 104: 647-656
49. Huttemann M, Lee I, Kreipke CW, Petrov T. Suppression of the inducible form of nitric oxide synthase prior to traumatic brain injury improves cytochrome c oxidase activity and normalizes cellular energy levels. Neuroscience 2008; 151: 148-154
50. Sharma N, Kress Y, Shafit-Zagardo B. Antisense map-2 oligonucleotides induce changes in microtubule assembly and neuritic elongation in pre-existing neurites of rat cortical neurons. Cell Motility & the Cytoskeleton 1994; 27: 234-247
51. Ryu JK, Cho T, Wang YT, McLarnon JG. Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed ad brain. Journal of Neuroinflammation 2009; 6: 39
52. Alfonso-Loeches S, Pascual M, Guerri C. Gender differences in alcohol-induced neurotoxicity and brain damage. Toxicology 2013; 311: 27-34
53. Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune response by head injury. Injury 2007; 38: 1392-400
54. Cafferty WB, Yang SH, Duffy PJ, Li S, Strittmatter SM. Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. Journal of Neuroscience 2007; 27: 2176-2185
55. Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006; 129: 2761-2772